ITIH5 and cancer: In the development of tumours, downregulation of ITIH5 expression caused by abnormal DNA hypermethylation has been reported in several types of cancers, including breast cancer13, bladder cancer14, colon cancer15, acute myeloid leukaemia16 and lung cancer17.